Diagnosis and therapy of fungal infection in immunocompromised patients has become increasingly important in the last several years. Because colonization of patients and medical devices with organisms such as Candida albicans, C. tropicalis, and C. parapsilosis frequently precedes the development of invasive disease with the same organisms (8, 10, 22, 26, 28) , it is important for the clinical laboratory to have the capability to rapidly and accurately identify both common and uncommon yeast isolates.
The inherent slowness of the standard methods for identifying clinical yeast isolates has greatly hindered the clinical usefulness of yeast identification. Conventional methods can require as long as 14 to 28 days for completion of biochemical tests (1, 12, 14, 16) . Some of the newer miniaturized systems such as the API 20C (Analytab Products, Plainview, N.Y.), the Minitek Yeast System (BBL Microbiology Systems, Cockeysville, Md.), and the Uni-Yeast-Tek (Flow Laboratories, Inc., McLean, Va.) may provide biochemical testing in 3 to 7 days, but despite this improvement, the results are frequently of retrospective interest only. A system that accurately identifies clinical yeast isolates in 24 h or less is sorely needed to provide the information necessary for optimal care of patients at risk for fungal infections.
One of the more recent advances in the rapid identification of yeast isolates is the use of chromogenic substrates to assess preformed enzyme activity. By detecting preformed enzymes, these systems provide a growth-independent means of identifying clinically important yeasts within 4 h of inoculation (3, 4, 24) . The API Yeast Ident system (Analytab) is the first commercially available product to utilize this approach for the identification of clinically important yeasts (24) . In The application of instrumentation to the various yeast identification systems allows automated or semi-automated test reading and interpretation, thus providing the potential for improved speed, standardization, accuracy, and reproducibility (6, 7, 13-15, 17, 19) . Although several large automated or semi-automated systems are available for yeast identification (6, 7, 13, 14, 19) , these instruments frequently do not fulfill the needs of smaller laboratories, many of which would benefit from rapid automated test reading and interpretation but do not have the necessary laboratory space or funds. The recent adaptation of the Abbott Yeast Identification System (6) to the Quantum II instrument (Abbott Laboratories, Irving, Tex.) appears to be a possible solution for laboratories which would like to progress beyond the slower manual yeast identification systems but stop short of the larger, more expensive automated systems. The Quantum II Yeast Identification System automatically reads and interprets the results of biochemical tests within 24 h of inoculation by using a photometer provided by the manufacturer. Although studies comparing the Quantum II with rapid manual yeast identification systems are necessary (11, 25, 27) The Quantum II tests were performed exactly as specified by the manufacturer. The test inoculum was prepared by suspending a portion of growth from an agar plate in a vial containing 0.5% Noble agar base medium (Difco) and adjusting the turbidity to match that of a no. 0.5 McFarland standard. The top of the 20-chamber cartridge was perforated, and 0.2 ml of the inoculum suspension was dispensed into each reaction chamber. and data management system of the AMS have been described in detail in previous publications (2, 7, 13, 14, 17, 19) .
All AMS-YBC procedures were conducted as directed by the manufacturer. An inoculum suspension was prepared by suspending a portion of a 48-h-old culture in 1.8 ml of 0.5% NaCl to a density equal to a no. 2 and L-leucyl-glycine-g-naphthylamide reactions.
Of the 37 misidentifications by AMS-YBC, 13 were at the genus level and 18 were at the species level, and in 6 instances no identification was assigned to organisms contained within the data base of AMS-YBC. AMS-YBC correctly classified 8 of 9 isolates of C. lusitaniae and 11 of 15 isolates of C. paratropicalis as not contained in the data base; however, several isolates including C. humicola, C. lambica, C. lusitaniae, C. paratropicalis, and Prototheca wickerhamii, which were not included in the AMS-YBC data base, were assigned incorrect identifications. As was observed with the Quantum Il and Yeast Ident systems, the misidentifications were due to multiple false-positive and false-negative biochemical tests. The organisms most frequently misidentified were C. tropicalis (7 isolates), C. parapsilosis (4 isolates), C. lambica (4 isolates), C. paratropicalis (4 isolates), and T. glabrata (4 isolates). These five yeasts accounted for 62% of all misidentifications by AMS-YBC.
DISCUSSION
The results obtained in the present study with the Quantum Il Yeast Identification System were similar to those reported by previous investigators (6, 11, 25, 27 (25) reported several physical problems with the Quantum Il system, we did not encounter problems with the inoculation, cartridge handling, or loading mechanism of the instrument.
The API Yeast Ident was significantly less accurate than either Quantum Il or AMS-YBC, regardless of whether common (69%) or uncommon (49%) isolates were considered. Like Salkin et al. (24), we found the data base to be quite limited and the tests involving aminopeptidase substrates to be very difficult to read and interpret. In addition, a large number of the biocodes were not listed in the API Analytical Profile Index, and an identification could be obtained only by calling the API computer service center. Although the Yeast Ident provided an identification in 4 h and hence was the most rapid of the three systems evaluated, it still required a delay of 48 h beyond primary isolation to obtain sufficient growth for inoculum preparation. Overall, the problems with the limited data base and test interpretation make the Yeast Ident system unacceptable for use in the clinical microbiology laboratory.
Previous studies comparing AMS-YBC with the API 20C or conventional identification systems have reported accuracies ranging from 84.0 to 99.0% (7, 13, 14, 19) . Land et al. (13) have described their experience with AMS-YBC following an expansion of the YBC data base and improvements in the data analysis scheme and construction of the taxonomic keys. In the first phase of their study, they found a 98.8% correlation between AMS-YBC and API 20C with a panel of 934 yeast isolates; however, a second randomized trial revealed an accuracy of 88% for the identification of varieties of less common perfect and imperfect yeasts. We found AMS-YBC to be somewhat less accurate than did Land et al. (13) and more comparable to the earlier results of Oblack et al. (19) and Hasyn and Buckley (7). These investigators reported overall accuracies of 84.9 and 84.0%, respectively, when compared with Uni-Yeast-Tek and API 20C. The overall accuracy of AMS-YBC (83%) in the present study was comparable to that of Quantum Il (82%) and significantly better than that of the API Yeast Ident system (60%). Although AMS-YBC was less accurate than Quantum Il in identifying common clinical isolates (86 versus 94%; P > 0.05), it was slightly better in identifying the less common isolates (80 versus 67%; P > 0.05). As with Quantum II, we did not observe any clustering of misidentifications or individual test discrepancies with AMS-YBC. On the basis of the data obtained in the present study, we believe that additional expansion of the AMS-YBC data base, particularly with the more common yeast isolates, is necessary before this system can be recommended for routine use. In addition to data base limitations, the accuracy of the Quantum Il, Yeast Ident, and AMS-YBC systems may be affected by the inoculum preparation. Organisms which are highly filamentous or encapsulated may pose particular problems in this regard owing to the difficulty in producing a standardized inoculum. Although we did not formally evaluate the effect of inoculum size in the present study, we did observe false-positive and false-negative test results in all systems when the inoculum size was too heavy or too light, respectively. Careful standardization of the inoculum preparation by using a spectrophotometer or hemacytometer may be necessary to ensure optimal performance with these and other yeast identification systems.
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